GB1129260A - Improvements in or relating to antacid compositions containing silicones - Google Patents

Improvements in or relating to antacid compositions containing silicones

Info

Publication number
GB1129260A
GB1129260A GB53253/66A GB5325366A GB1129260A GB 1129260 A GB1129260 A GB 1129260A GB 53253/66 A GB53253/66 A GB 53253/66A GB 5325366 A GB5325366 A GB 5325366A GB 1129260 A GB1129260 A GB 1129260A
Authority
GB
United Kingdom
Prior art keywords
antacid
granules
aluminium
relating
compositions containing
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
GB53253/66A
Other languages
English (en)
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Smith Kline and French Laboratories Ltd
Original Assignee
Smith Kline and French Laboratories Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Smith Kline and French Laboratories Ltd filed Critical Smith Kline and French Laboratories Ltd
Publication of GB1129260A publication Critical patent/GB1129260A/en
Expired legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/74—Synthetic polymeric materials
    • A61K31/80—Polymers containing hetero atoms not provided for in groups A61K31/755 - A61K31/795
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/141—Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers
    • A61K9/145—Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers with organic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2072—Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms
    • A61K9/2077—Tablets comprising drug-containing microparticles in a substantial amount of supporting matrix; Multiparticulate tablets
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4808—Preparations in capsules, e.g. of gelatin, of chocolate characterised by the form of the capsule or the structure of the filling; Capsules containing small tablets; Capsules with outer layer for immediate drug release
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01D—SEPARATION
    • B01D19/00—Degasification of liquids
    • B01D19/02—Foam dispersion or prevention
    • B01D19/04—Foam dispersion or prevention by addition of chemical substances
    • B01D19/0404—Foam dispersion or prevention by addition of chemical substances characterised by the nature of the chemical substance
    • B01D19/0409—Foam dispersion or prevention by addition of chemical substances characterised by the nature of the chemical substance compounds containing Si-atoms

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Toxicology (AREA)
  • Dispersion Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
GB53253/66A 1965-12-06 1966-11-28 Improvements in or relating to antacid compositions containing silicones Expired GB1129260A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CA947065 1965-12-06

Publications (1)

Publication Number Publication Date
GB1129260A true GB1129260A (en) 1968-10-02

Family

ID=4142389

Family Applications (1)

Application Number Title Priority Date Filing Date
GB53253/66A Expired GB1129260A (en) 1965-12-06 1966-11-28 Improvements in or relating to antacid compositions containing silicones

Country Status (10)

Country Link
US (1) US3501571A (https=)
BE (1) BE690679A (https=)
BR (1) BR6685118D0 (https=)
DE (1) DE1617800A1 (https=)
DK (1) DK116020B (https=)
FR (2) FR6885M (https=)
GB (1) GB1129260A (https=)
IL (1) IL26885A (https=)
NL (1) NL6617127A (https=)
SE (1) SE348940B (https=)

Cited By (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4127650A (en) * 1975-03-31 1978-11-28 William H. Rorer, Inc. Medicinal simethicone containing composition and its method of production
US4396604A (en) * 1982-05-17 1983-08-02 Norcliff Thayer, Inc. Simethicone antacid lozenge
US5458886A (en) * 1993-06-04 1995-10-17 Dow Corning France S.A. Antifoam compositions
DE102012024434A1 (de) * 2012-12-14 2014-06-18 Regalismons S.A. Verstärkung der entschäumenden Wirkung von Polysiloxanen, zugehöriger Zusammensetzungen und Lösungen

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA885974A (en) * 1968-04-02 1971-11-16 Mowatt And Moore Limited Ferrous fumarate capsule and preparation
GB1357737A (en) * 1970-10-09 1974-06-26 Arpic Sa Sustained release pharmaceutical compositions
JPS51123814A (en) * 1975-04-22 1976-10-28 Shin Etsu Chem Co Ltd A process for preparing gradually releasable solid medicines
US4198390A (en) * 1979-01-31 1980-04-15 Rider Joseph A Simethicone antacid tablet
EP0207405B1 (en) * 1982-07-27 1990-03-21 Mylan Pharmaceuticals, Inc. Method for making pharmaceutical combination composition in granularly heterogenous solid unit dosage form with enhanced bioavailability
US4594243A (en) * 1984-07-25 1986-06-10 Nitto Electric Industrial Co., Ltd. Base composition for medicament and pharmaceutical composition for external medication
EP0294933B1 (en) * 1987-05-08 1992-03-11 Smith Kline & French Laboratories Limited Pharmaceutical compositions
GB8710965D0 (en) * 1987-05-08 1987-06-10 Smith Kline French Lab Pharmaceutical compositions
HU206624B (en) * 1989-01-19 1992-12-28 Steigerwald Arzneimittelwerk Process for producing pharmaceutical composition for treating illnesses of oesophagus and the gastro-intestinal system
US5073384A (en) * 1989-10-19 1991-12-17 Valentine Enterprises, Inc. Maltodextrin/defoaming composition combinate
USRE35893E (en) * 1989-10-19 1998-09-08 Valentine Enterprises, Inc. Defoaming composition
US5275822A (en) * 1989-10-19 1994-01-04 Valentine Enterprises, Inc. Defoaming composition
DE3937455A1 (de) * 1989-11-10 1991-05-16 Nordmark Arzneimittel Gmbh Antacidatabletten
US6399591B1 (en) * 2000-01-19 2002-06-04 Yung-Shin Pharmaceutical Ind. Co., Ltd. Chargeable pharmaceutical tablets

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2477080A (en) * 1947-07-15 1949-07-26 Michael Reese Res Foundation Antacid preparation
USRE25205E (en) * 1960-10-10 1962-07-24 Silicone composition for the relief of
AU407324B2 (en) * 1962-05-01 1970-10-28 Smith, Kline & French Laboratories Powdered silicone products and processes
FR175F (https=) * 1964-05-25 1900-01-01

Cited By (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4127650A (en) * 1975-03-31 1978-11-28 William H. Rorer, Inc. Medicinal simethicone containing composition and its method of production
US4396604A (en) * 1982-05-17 1983-08-02 Norcliff Thayer, Inc. Simethicone antacid lozenge
US5458886A (en) * 1993-06-04 1995-10-17 Dow Corning France S.A. Antifoam compositions
DE102012024434A1 (de) * 2012-12-14 2014-06-18 Regalismons S.A. Verstärkung der entschäumenden Wirkung von Polysiloxanen, zugehöriger Zusammensetzungen und Lösungen
US10617761B2 (en) 2012-12-14 2020-04-14 Regalismons S.A. Compositions and solutions for colon cleansing

Also Published As

Publication number Publication date
BR6685118D0 (pt) 1973-12-04
FR1515061A (fr) 1968-03-01
IL26885A (en) 1970-10-30
SE348940B (https=) 1972-09-18
US3501571A (en) 1970-03-17
BE690679A (https=) 1967-06-05
DE1617800A1 (de) 1971-04-08
NL6617127A (https=) 1967-06-07
DK116020B (da) 1969-12-01
FR6885M (https=) 1969-04-21

Similar Documents

Publication Publication Date Title
GB1129260A (en) Improvements in or relating to antacid compositions containing silicones
JPS5268191A (en) Preparation of 22substituted 44aminoo6*7*88 trialkoxy quinazoline
ZA722050B (en) Liquid compositions
ES314080A1 (es) Mejoras introducidas en la preparacion de composiciones de silice y alumina.
IL39505A0 (en) Pesticidal compositions containing araliphatic nitriles and the preparation of the active ingredients thereof
CA982290A (en) Viscosity stabilized wax emulsion polish composition
AU4115672A (en) Surface treating compositions containing ammonioamidate compounds
CA968710A (en) Anabolic compositions containing 19-nor-spiroxenone
GB1182655A (en) Colour Stabilized Compositions containing Alkylated Phenols
CA980687A (en) Veterinary compositions containing sulfonamide compounds
AU456659B2 (en) Clear liquid laxative antacid composition
GB1371865A (en) Antimicrobial compositions containing aluminum halide compounds
CA953254A (en) Device for the storage, mixing and dispensing of ingredients
AU2640071A (en) Flame-retarded compositions
IL37212A (en) The preparation of surface-active compositions
GB1272340A (en) Derivatives of neriifolin
AU462266B2 (en) Improved cement compositions andthe preparation thereof
IL37460A (en) Stabilized insecticidal compositions containing geranyl phenyl ethers
Roark The thermal decomposition of 7, 8-disilabicyclo [2.2. 2] octa-2, 5-dienes: evidence for the transient existence of silicon-silicon double bonds
GB1236880A (en) Antacid compositions
CA958841A (en) Stabilized compositions containing alkylated p-hydroxyphenylalkyl phosphinates
AU3116171A (en) Mixture composition monitor
GB1106326A (en) m-amylphenyl-n-methylcarbamate
CA835415A (en) Mixed alkyl analogs of ddvp and their use as anthelmintics
CA864524A (en) Antacid compositions